Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cross SJ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 32
Tytuł:
Five Inhibitory Receptors Display Distinct Vesicular Distributions in Murine T Cells.
Autorzy:
Lu J; School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.; Department of Urology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai 200032, China.
Veler A; School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Simonetti B; School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
Raj T; School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Chou PH; School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Cross SJ; Wolfson Bioimaging Facility, University of Bristol, Bristol BS8 1TD, UK.
Phillips AM; Department of Electrical Engineering & Electronics and Computational Biology Facility, University of Liverpool, Liverpool L69 7ZX, UK.
Ruan X; Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Huynh L; School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Dowsey AW; Bristol Veterinary School, University of Bristol, Bristol BS40 5DU, UK.
Ye D; Department of Urology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai 200032, China.; Shanghai Genitourinary Cancer Institute, Shanghai 200032, China.
Murphy RF; Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA.; Department of Biological Sciences, Biomedical Engineering and Machine Learning, Carnegie Mellon University, Pittsburgh, PA 15213, USA.
Verkade P; School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
Cullen PJ; School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
Wülfing C; School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Oct 31; Vol. 12 (21). Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:
Journal Article
MeSH Terms:
T-Lymphocytes*
Neoplasms*/metabolism
Mice ; Animals ; CTLA-4 Antigen/metabolism ; Carrier Proteins/metabolism ; Immunotherapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Healthcare-Associated Infections Caused by Mycolicibacterium neoaurum.
Autorzy:
Shapiro K
Cross SJ
Morton TH
Inaba H
Holland A
Fasipe FR
Adderson EE
Pokaż więcej
Źródło:
Emerging infectious diseases [Emerg Infect Dis] 2023 Aug; Vol. 29 (8).
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Cross Infection*
Mycobacteriaceae*
Mycobacterium*
Mycobacterium Infections*/microbiology
Child ; Humans ; Middle Aged ; Delivery of Health Care ; Young Adult
SCR Organism:
Mycolicibacterium neoaurum
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Human Astrovirus VA1 Encephalitis in Pediatric Patients With Cancer: Report of 2 Cases and Review of the Literature.
Autorzy:
Bami S; Hospitalist Medicine Program, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Hidinger J; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Madni A; Hospitalist Medicine Program, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Division of Quality of Life and Palliative Care, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Hargest V; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Schultz-Cherry S; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Cortez V; Department of Molecular and Cell & Developmental Biology, University of California, Santa Cruz, California, USA.
Cross SJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Ward DA; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Hayden RT; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Rubnitz J; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pui CH; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Khan RB; Division of Neurology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Hijano DR; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2022 Sep 29; Vol. 11 (9), pp. 408-412.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Astroviridae Infections*/diagnosis
Encephalitis*
Mamastrovirus*/genetics
Neoplasms*
Child ; Feces ; Humans ; Immunocompromised Host ; Phylogeny
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adenosine 2A receptor and TIM3 suppress cytolytic killing of tumor cells via cytoskeletal polarization.
Autorzy:
Edmunds GL; School of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.
Wong CCW; School of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.
Ambler R; School of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.
Milodowski EJ; Bristol Veterinary School, University of Bristol, Bristol, BS40 5DU, UK.
Alamir H; School of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.
Cross SJ; Wolfson BioImaging Facility, University of Bristol, Bristol, BS8 1TD, UK.
Galea G; School of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK.
Wülfing C; School of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK. .
Morgan DJ; School of Cellular and Molecular Medicine, University of Bristol, Bristol, BS8 1TD, UK. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2022 Jan 10; Vol. 5 (1), pp. 9. Date of Electronic Publication: 2022 Jan 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Death*
Cytoskeleton/*physiology
Cytosol/*physiology
Hepatitis A Virus Cellular Receptor 2/*genetics
Receptor, Adenosine A2A/*genetics
Adenosine A2 Receptor Agonists/pharmacology ; Animals ; Cell Line, Tumor ; Female ; Hepatitis A Virus Cellular Receptor 2/metabolism ; Male ; Mice ; Mice, Inbred BALB C ; Receptor, Adenosine A2A/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Epidemiology, Diagnosis, and Treatment of Clostridioides difficile Infection in Immunocompromised Children.
Autorzy:
Cross SJ; Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Morton TH; Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee, USA.; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Wolf J; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2021 Nov 17; Vol. 10 (Supplement_3), pp. S46-S51.
Typ publikacji:
Journal Article
MeSH Terms:
Clostridioides difficile*
Clostridium Infections*/diagnosis
Clostridium Infections*/drug therapy
Clostridium Infections*/epidemiology
Anti-Bacterial Agents/therapeutic use ; Asymptomatic Infections ; Child ; Clostridioides ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.
Autorzy:
Chiotos K; Division of Critical Care Medicine, Department of Anesthesia and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Antimicrobial Stewardship Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Hayes M; Antimicrobial Stewardship Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Kimberlin DW; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jones SB; Department of Pharmacy, Boston Children's Hospital, Boston, Massachusetts, USA.; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.
James SH; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pinninti SG; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Yarbrough A; Department of Pharmacy, Children's of Alabama, Birmingham, Alabama, USA.
Abzug MJ; Division of Infectious Diseases, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
MacBrayne CE; Department of Pharmacy, Children's Hospital Colorado, Aurora, Colorado, USA.
Soma VL; Division of Infectious Diseases, Department of Pediatrics, New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, USA.
Dulek DE; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University and Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA.
Vora SB; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.
Waghmare A; Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Wolf J; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Olivero R; Section of Infectious Diseases, Department of Pediatrics and Human Development, Helen DeVos Children's Hospital of Spectrum Health, Michigan State College of Human Medicine, Grand Rapids, Michigan, USA.
Grapentine S; Department of Pharmacy, University of California-San Francisco Benioff Children's Hospital, San Francisco, California, USA.
Wattier RL; Division of Infectious Diseases and Global Health, Department of Pediatrics, University of California-San Francisco, San Francisco, California, USA.
Bio L; Department of Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, California, USA.
Cross SJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Dillman NO; Department of Pharmacy, CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Downes KJ; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Oliveira CR; Yale University School of Medicine, Yale University, New Haven, Connecticut, USA.
Timberlake K; Department of Pharmacy, The Hospital for Sick Children, Toronto, Ontario, Canada.
Young J; Department of Pharmacy, St. Louis Children's Hospital, St. Louis, Missouri, USA.
Orscheln RC; Division of Infectious Diseases, Department of Pediatrics, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Tamma PD; Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Schwenk HT; Division of Infectious Diseases, Department of Pediatrics, Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford, Stanford, California, USA.
Zachariah P; Division of Infectious Diseases, Department of Pediatrics, Columbia University, New York, New York, USA.
Aldrich ML; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.
Goldman DL; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital at Montefiore, New York, New York, USA.
Groves HE; Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
Rajapakse NS; Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Lamb GS; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Tribble AC; Department of Pediatrics, Division of Infectious Diseases, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Hersh AL; Division of Infectious Diseases, Department of Pediatrics, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Thorell EA; Division of Infectious Diseases, Department of Pediatrics, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Denison MR; Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University and Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA.
Ratner AJ; Division of Infectious Diseases, Department of Pediatrics, New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, USA.; Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Newland JG; Division of Infectious Diseases, Department of Pediatrics, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Nakamura MM; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2021 Feb 13; Vol. 10 (1), pp. 34-48.
Typ publikacji:
Consensus Development Conference; Journal Article
MeSH Terms:
COVID-19 Drug Treatment*
Antiviral Agents/*therapeutic use
Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/therapeutic use ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; COVID-19/therapy ; Child ; Evidence-Based Medicine ; Humans ; Immunocompromised Host ; Risk Factors ; Severity of Illness Index ; Systemic Inflammatory Response Syndrome/drug therapy
SCR Disease Name:
pediatric multisystem inflammatory disease, COVID-19 related
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.
Autorzy:
Chiotos K; Department of Anesthesia and Critical Care Medicine, Division of Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Antimicrobial Stewardship Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Hayes M; Antimicrobial Stewardship Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Kimberlin DW; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jones SB; Department of Pharmacy, Boston Children's Hospital, Boston, Massachusetts, USA.; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.
James SH; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pinninti SG; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Yarbrough A; Department of Pharmacy, Children's of Alabama, Birmingham, Alabama, USA.
Abzug MJ; Department of Pediatrics, Division of Infectious Diseases, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
MacBrayne CE; Department of Pharmacy, Children's Hospital Colorado, Aurora, Colorado, USA.
Soma VL; Department of Pediatrics, Division of Infectious Diseases, New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, USA.
Dulek DE; Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University and Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA.
Vora SB; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.
Waghmare A; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington, Seattle Children's Hospital, Seattle, Washington, USA.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Wolf J; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Olivero R; Department of Pediatrics and Human Development, Section of Infectious Diseases, Helen DeVos Children's Hospital of Spectrum Health, Michigan State College of Human Medicine, Grand Rapids, Michigan, USA.
Grapentine S; Department of Pharmacy, University of California-San Francisco Benioff Children's Hospital, San Francisco, California, USA.
Wattier RL; Department of Pediatrics, Division of Infectious Diseases and Global Health, University of California-San Francisco, San Francisco, California, USA.
Bio L; Department of Pharmacy, Lucile Packard Children's Hospital Stanford, Stanford, California, USA.
Cross SJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Dillman NO; Department of Pharmacy, CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Downes KJ; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Timberlake K; Department of Pharmacy, The Hospital for Sick Children, Toronto, Canada.
Young J; Department of Pharmacy, St. Louis Children's Hospital, St. Louis, Missouri, USA.
Orscheln RC; Department of Pediatrics, Division of Infectious Diseases, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Tamma PD; Department of Pediatrics, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Schwenk HT; Department of Pediatrics, Division of Infectious Diseases, Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford, Stanford, California, USA.
Zachariah P; Department of Pediatrics, Division of Infectious Diseases, Columbia University Irving Medical Center, New York, New York, USA.
Aldrich M; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital at Montefiore, New York, New York, USA.
Goldman DL; Department of Pediatrics, Division of Infectious Diseases, Children's Hospital at Montefiore, New York, New York, USA.
Groves HE; Department of Pediatrics, Division of Infectious Diseases, Hospital for Sick Children, Toronto, Canada.
Lamb GS; Department of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
Tribble AC; Department of Pediatrics, Division of Infectious Diseases, University of Michigan and CS Mott Children's Hospital, Ann Arbor, Michigan, USA.
Hersh AL; Department of Pediatrics, Division of Infectious Diseases, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Thorell EA; Department of Pediatrics, Division of Infectious Diseases, University of Utah and Primary Children's Hospital, Salt Lake City, Utah, USA.
Denison MR; Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University and Monroe Carell Jr. Children's Hospital, Nashville, Tennessee, USA.
Ratner AJ; Department of Pediatrics, Division of Infectious Diseases, New York University Grossman School of Medicine and Hassenfeld Children's Hospital, New York, New York, USA.; Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.
Newland JG; Department of Pediatrics, Division of Infectious Diseases, Washington University and St. Louis Children's Hospital, St. Louis, Missouri, USA.
Nakamura MM; Antimicrobial Stewardship Program, Boston Children's Hospital, Boston, Massachusetts, USA.; Department of Pediatrics, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2020 Dec 31; Vol. 9 (6), pp. 701-715.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
COVID-19 Drug Treatment*
Antiviral Agents/*therapeutic use
Child ; Humans ; Risk Assessment ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Aerogen Solo Is an Alternative to the Small Particle Aerosol Generator (SPAG-2) for Administration of Inhaled Ribavirin.
Autorzy:
Dallas RH; Department of Infectious Diseases, St. Jude Children Research Hospital, Memphis, TN 38105, USA.
Rains JK; Department of Critical Care and Pulmonary Medicine, St. Jude Children Research Hospital, Memphis, TN 38105, USA.
Wilder K; Department of Critical Care and Pulmonary Medicine, St. Jude Children Research Hospital, Memphis, TN 38105, USA.
Humphrey W; Department of Pharmaceutical Sciences, St. Jude Children Research Hospital, Memphis, TN 38105, USA.
Cross SJ; Department of Pharmaceutical Sciences, St. Jude Children Research Hospital, Memphis, TN 38105, USA.
Ghafoor S; Department of Critical Care and Pulmonary Medicine, St. Jude Children Research Hospital, Memphis, TN 38105, USA.
Brazelton de Cardenas JN; Department of Pathology, St. Jude Children Research Hospital, Memphis, TN 38105, USA.
Hayden RT; Department of Pathology, St. Jude Children Research Hospital, Memphis, TN 38105, USA.
Hijano DR; Department of Infectious Diseases, St. Jude Children Research Hospital, Memphis, TN 38105, USA.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2020 Nov 29; Vol. 12 (12). Date of Electronic Publication: 2020 Nov 29.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
Autorzy:
Karol SE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Sun Y; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Tang L; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Pui CH; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.
Ferrolino J; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.
Allison KJ; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.
Cross SJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Evans WE; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Crews KR; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jeha S; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.
Wolf J; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA.; Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2020 Sep; Vol. 9 (18), pp. 6550-6555. Date of Electronic Publication: 2020 Jul 25.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Antibiotic Prophylaxis*/adverse effects
Anti-Bacterial Agents/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Fluoroquinolones/*administration & dosage
Neurotoxicity Syndromes/*etiology
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*drug therapy
Vincristine/*adverse effects
Adolescent ; Age Factors ; Anti-Bacterial Agents/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Child ; Child, Preschool ; Female ; Fluoroquinolones/adverse effects ; Humans ; Induction Chemotherapy/adverse effects ; Infant ; Infant, Newborn ; Male ; Motor Neurons/drug effects ; Neuralgia/chemically induced ; Neuralgia/physiopathology ; Neurotoxicity Syndromes/diagnosis ; Neurotoxicity Syndromes/physiopathology ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Sensory Receptor Cells/drug effects ; Time Factors ; Treatment Outcome ; Vincristine/administration & dosage
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 32

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies